[en] The sensitivity of bovine platelet aggregation in response to PAF stimulation and the ability of WEB 2086 (a thieno-triazolodiazepine) to inhibit response to PAF-induced platelet aggregation were investigated in the blood from five healthy male Belgian Blue calves. The recorded response to PAF showed a plateau which was dependent on the PAF concentration. Platelet aggregation induced by PAF consists of two mechanisms: reversible and irreversible aggregations which are accompanied by the release of platelet granule contents. Reversible aggregation occurred above (2 . 10(-9) mol/l) PAF, and irreversible aggregation occurred above (2 . 10(-7) mol/l) PAF. Addition of WEB 2086 to bovine platelets in vitro induced a rightward shift in the dose-response curve to PAF. WEB 2086 inhibited PAF-induced aggregation in a competitive reversible manner (pA2 = 7.61). The results of our study show that PAF induces platelet aggregation in platelet-rich plasma (PRP) and that addition of WEB 2086 to bovine platelets in vitro inhibits PAF-induced Platelet Aggregation.
Disciplines :
Anatomy (cytology, histology, embryology...) & physiology Veterinary medicine & animal health
Author, co-author :
Bastos da Silva, Miriam; Université de Liège - ULiège > Faculty of Veterinary Medicine > Laboratory for Functional Investigation
Herion, Francine ; Centre Hospitalier Universitaire de Liège - CHU > Thrombosis Hemostasis Unit
Raskinet, Renée ; Centre Hospitalier Universitaire de Liège - CHU > Thrombosis Hemostasis Unit
David, Jean-Louis ; Université de Liège - ULiège > Thrombosis Hemostasis Unit
Gustin, Pascal ; Université de Liège - ULiège > Pharmacology and Toxicology
Dessy, Cécile ; Université de Liège - ULiège > Faculty of Veterinary Medicine > Histology
Lekeux, Pierre ; Université de Liège - ULiège > Faculty of Veterinary Medicine > Laboratory for Functional Investigation
Language :
English
Title :
Inhibition of Paf-Induced Platelet Aggregation by Web 2086 'in-Vitro', an Antagonist to the Receptor for Platelet-Activating Factor, in Bovine
Publication date :
1996
Journal title :
Journal of Veterinary Medicine. A, Physiology, Pathology, Clinical Medicine
ISSN :
0931-184X
eISSN :
1439-0442
Publisher :
Blackwell Publishing, Berlin, Germany
Volume :
43
Issue :
7
Pages :
399-413
Peer reviewed :
Peer Reviewed verified by ORBi
Funders :
CNPq - Conselho Nacional de Desenvolvimento Científico e Tecnológico
Funding text :
Bastos is a recipient of a grant from CNPq and FCAP Belém-Parà Brazil
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
BIRKE, F. W., and K. H. WEBER, 1988: Specific and high affinity binding of WEB 2086 to human platelet PAF receptors. Clin. Exper. Pharmacol. Physiol. Suppl. 13, 2.
BONDY, G. S., and P. A. GENTRY, 1989: Characterization of the normal bovine platelet aggregation response. Comp. Biochem. Physiol. C92, 67-72.
BORN, G. V. R., and M J. CROSS, 1963: The aggregation of blood platelets J. Physiol. (Lond), 168, 178-195.
BRAQUET, P., L. TOUQUI, T. Y. SHEN, and B. B. VARGAFTIG, 1987: Perspectives in platelet-activating factor research Pharmacol. Rev. 39, 97-145.
CARGILL, D. I, D. S. COHEN, R. G. VAN VALEN, J. J. KLINFK and R. P. LEVIN, 1989: Aggregation, release and desensitization induced in platelets from five species by platelet activating factor (PAF). Thromb. Haemost. 49, 204-207.
CASALS-STENZEL, J., and K. H. WEBER, 1987: Triazolodiazepines: dissociation of their PAF (platelet-activating factor) antagonistc and CNS activity. Br. J. Pharmac. 90, 139-146.
CHAN, W. P., and J V. LEVY, 1991: Effects of antiplatelet agents on platelet aggregation induced by platelet-activating factor (PAF) in human whole blood Prostaglandins 42, 337-342.
CHAP, H., G. MAUCO, M. F. SIMON, J. BENVENISTE, and L. DOUSTE-BLAZY, L., 1981: Biosynthetic labelling of platelet activating factor from radioactive acetate by stimulated platelets. Nature (Lond.) 289, 312-314
CHIGNARD, M., J. P. LE COUEDIC, M. TENCE, B. B. VARGAFTIG, and J. BENVENISTE, 1979: The role of platelet-activating factor in platelet aggregation. Nature 279, 799-800
CHUNG, K. F., 1992: Platelet-activating factor in inflammation and pulmonary disorders. Clin. Sci. 83, 127-138.
CUSAK, N. J., 1980: Platelet-activating factor. Nature 285, 22.
DAVID, J.-L., F. MONFORT, F. HERION, and R. RASKINET, 1979: Compared effects of three dose-levels of Ticlopidine on Platelet function in normal subjects. Thromb. Res. 14, 35-49.
FOSTER, A. P., P. LEES, M. J. ANDREWS, and F. M. CUNNINGHAM, 1992: Effects of WEB 2086, an antagonist to the receptor for platelet-activating factor (PAF), on PAF-induced responses in the horse. Equine Vet. J. 24, 203-207.
FOSTER, A. P., F. M. CUNNINGHAM, M. J. ANDREWS, and P. LEES, 1993: A comparison of the action of platelet factor (PAF) antagonists WEB2170 and 2086 in the horse. J. Vet. Pharmacol. Ther. 16, 477-487.
GODFROID, J. J., F. HEYMANS, E. MICHEL, C. REDEVILH, E. STEINER, and J. BENVENISTE, 1980: Platelet-activating factor (PAF-acether): Total synthesis of 1-0-octadecyl 2-0-acetyl sn-glycero-3-phosphorylcoline. FEBS Lett. 116, 161-164.
GROUSE, L. H., G. H. R. RAO, D. J. WEISS, V. PERMAN, and J. G. WHITE, 1990: Surface-activated bovine platelets do not spread, they unfold. Am. J. Pathol. 136, 399-408.
KENAKIN, T. P., 1987: Pharmacological analysis of drug receptor interaction. pp. 210-217, Raven, New York.
KOJIMA, S., H. HAGIWARA, W. SOGA, F. SEKIYA, Y. SAITO, and Y. INADA, 1987: Cooperativity between platelet-activating factor and collagen in platelet aggregation. Biochem. Biophys. Res. Commun. 145, 915-920.
KOJIMA, S., F. SEKIYA, Y. INADA, T. TSUKADA, and Y SAITO, 1990: Cooperativity between platelet-activating factor and collagen in aggregation of bovine platelets III. FEBS Lett. 267, 226-228.
KORNECKI, E., 1984: Platelet-activating factor-induced aggregation of human platelets specifically inhibited by Triazolodiazepines. Science 226, 1454-1456.
KORTH, R., M. HIRAFUJI, C. L. KERALY, D. DELAUTIER, J. BIDAUT, and J. BENVENISTE, 1989: Interaction of the Paf antagonist WEB 2086 and its hetrazepine analogues with human platelets and endothelial cells. Br. J. Pharmacol. 98, 653-661.
LEVY, J. V., and K. EZZET, 1987: Schild plot analysis of six putative antagonist of platelet activating factor (PAF) on human platelets. Pharmacologist 29, 219.
LIGGITT, H. D., R. W. LEID, and L. HUSTON, 1984: Aggregation of bovine platelets by acetyl gryceril ether phosphorylcholine (Platelet activating factor). Veterinary Immunol. Immunopathol. 7, 81-87.
MARCUS, A. J., L. B. SAFIER, and H. L. ULLMAN, 1981: Effects of acteyl glyceryl ether phosphorylcholine on human platelet function in vitro. Blood 58, 1027-1031.
MATTHIAS, T. T., 1987: Blood coagulations disorders, Chap. 1. Springer Verlag. Berlin-Heidelberg. p. 19-29.
MEADE, C. J., H. HEUER, and R. KEMPE, 1991: Biochemical pharmacology of platelet-activating factor (and PAF antagonists) in relation to clinical and experimental thrombocytopenia. Biochem. Pharmacol. 41, 657-668.
MEYERS, K. M., J. B. KATZ, R. M. GLEMMONS, J. B. SMITH, and H. HOLMSEN, 1980: An evaluation of the arachidonate pathway of platelets from companion and food-producing animals, mink and man. Thromb. Res. 20, 13-24.
MCCULLOCH, R. K., AND R. VANDOGEN, 1990: Mechanism of platelet activating factor-induced aggregation and secretion in human platelets. Prostaglandins 39, 13-21.
MCMANUS, L. M., D. J. HANAHAN, and R. N. PINCKARD, 1981: Human platelet stimulation by acetyl glyceryl ether phosphorylcholine. J. Clin. Invest. 67, 903-906.
NAMM, D. H., A. S. TADEPALLI, and J. A. HIGH, 1982: Species specificity of the platelet responses to 1-0-alkyl-2-acetyl-sn-glycero-3phosphocholine. Thromb. Res. 25, 341-350.
O'DONNEL, S. R., and C. J. K. BARNETT, 1988: PA2 values for antagonists of platelet activating factor on aggregation of rabbit platelets. Br. J. Pharmacol. 94, 437-442.
RAUCHLE, K L., S. R. O'DONNELL, C. J. K. BARNNETT, and X-P. ZENG, 1989: A comparison of the heterazepine PAF antagonists WEB2086, WEB2170 and STY2180. Clin. Exp. Pharmacol. Physiol. suppl 14, Abstract 176.
SAUDERS, R. N., and D. A. HANDLEY, 1987: Platelet-activating factor antagonists. Ann. Rev. Pharmacol. Toxicol. 27, 237-255.
SCHORDERET, M., 1988: Pharmacologie. Des concepts fondamentaux aux applications thérapeutiques. Frison-Roché, Paris. Slaktine, Ed. Slaktine, p. 3-19.
SOLOVIEV, A. I., and P. BRAQUET, 1992: Platelet-activating factor - A potent endogenous mediator responsible for coronary vasospasm. NIPS 7, 166-172.
SPENCE, D. P. S., S. L. JOHNSTON, P. M. A. CALVERLEY, P. DHILLON, C. HIGGINS, E. RAMHAMADY, S. TURNER, A. WINNINHG, J. WINTER, and S. T. HOLGATE, 1994: The effect of the orally active Platelet-activating factor antagonist WEB 2086 in the treatment of Asthma. Am. J. Respir. Crit. Care Med. 149, 1142-1148.
STEEL, R. G. D., and J. M. TORRIE, 1980: Principles and procedures of statistics a biometrical approach. McGraw-Hill International Editions - Statistics Series, New York. 2nd. edn, p. 185-186.
STEWART, A. G., and G. J. DUSTING, 1988: Characterization of receptors for platelet-activating factor on platelets, polymorphonuclear leukocytes and macrophages. Br. J. Pharmacol. 94, 1225-1233.
SUQUET, C. M., and R. W. LEID, 1983: Aggregation of equine platelets by PAF (Platelet-activating factor), Inflammation 7, 197-203.
TAHRAOUI, L., A. FLOCH, S. MONDOT, and I. CAVERO, 1988: High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: Counterparts of platelet-activating factor receptors mediating platelet aggregation. Mol. Pharmacol. 34, 145-151.
UKENA, D., G. DENT, C. ROBAUT, F. W. BIRKE, G. W. SYBRECHT, and P. J. BARNES, 1988: Radioligand binding of antagonists of platelet-activating factor to intact human platelet. FEBS Lett. 228, 285-289.
VARGAFTIG, B. B., M. CHIGNARD, and J. BENVENISTE, 1981: Present concepts on the mechanism of platelet aggregation. Biochem. Pharmacol. 30, 263-271.
VIEIRA, S., 1985: Introdução a Bioestatística. 3a. ed. pp. 223-245, Editora Campus Ltda, Rio de Janeiro.
WHITE, J. G., 1987: The secretory pathway of bovine platelets. Blood 69, 878-885.
ZUCKER-FRANKIN, D., K. A. BENSON, and M. M. KENNETH, 1985: Absence of a surface-connected canalicular system in bovine platelets. Blood 65, 241-244.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.
